EX-12.1 5 f78520ex12-1.txt EXHIBIT 12.1 EXHIBIT 12.1 SCICLONE PHARMACEUTICALS, INC. COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES (IN THOUSANDS)
FISCAL YEAR ENDED DECEMBER 31, 2001 2000 1999 1998 1997 ------------- ------------- ------------- -------------- -------------- Interest expense 314,666.67 36,000.00 -- -- -- Int Cap during period 19,007.28 -- Portion of rent exp representive of int 427,680.00 164,340.00 131,340.00 152,130.00 152,460.00 -------------------------------------------------------------------------------- Fixed Charges 761,353.95 200,340.00 131,340.00 152,130.00 152,460.00 EARNINGS Income before income tax (6,232,721.00) (1,717,454.00) (5,466,606.00) (24,213,245.00) (13,997,005.00) Fixed charges 761,353.95 200,340.00 131,340.00 152,130.00 152,460.00 Int Cap during period (19,007.28) -------------------------------------------------------------------------------- (5,490,374.33) (1,517,114.00) (5,335,266.00) (24,061,115.00) (13,844,545.00) Ratio of earnings to fix charges n/m n/m n/m n/m n/m
(1) We have computed the ratios of earnings to fixed charges by dividing income (loss) before income taxes plus fixed charges by fixed charges. For the periods presented, fixed charges consisted of interest expensed, capitalized expenses related to indebtedness, and the estimated portion of rental expense for operating leases that represents interest. Earnings were insufficient to cover fixed charges for the years ended December 31, 2001, 2000, 1999, 1998, and 1997 by approximately $6.2 million, $1.7 million, $5.5 million, $24.2 million, and $14.0 million, respectively.